Payment overview · 2025
General Payments
$162.40
9 reported records · 4 companies
Healthcare provider profile · identity verified
Jerrold Randall Ecklind, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · WILDWOOD, FL · NPI 1851390322
Verified facts
What the public records show
CMS Open Payments records show Jerrold Randall Ecklind, D.O. received $162.40 in general payments during 2025 across 9 reported records.
AstraZeneca Pharmaceuticals LP accounted for 44.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 47 claims for Symbicort by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 131 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $72.08 | 44.4% | 4 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $55.11 | 33.9% | 3 | 2025 |
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.04 | 12.3% | 1 | 2025 |
| SHIELD THERAPEUTICS INC | Unresolved — no canonical attribution shown | $15.17 | 9.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $162.40 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $58.09 | 3 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $55.11 | 3 | 2025 |
Source payment records
|
|||||
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $20.04 | 1 | 2025 |
Source payment records
|
|||||
| ACCRUFER Normalized: accrufer |
Drug | SHIELD THERAPEUTICS INC | $15.17 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $14.50 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $13.99 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 131 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
34 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
47 | 13 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
131 | 41 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1077 | 313 |
| Alprazolam | Alprazolam | 970 | 157 |
| Amlodipine Besylate | Amlodipine Besylate | 794 | 244 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 721 | 136 |
| Lisinopril | Lisinopril | 705 | 206 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 703 | 91 |
| Levothyroxine Sodium | Levothyroxine Sodium | 702 | 193 |
| Omeprazole | Omeprazole | 688 | 208 |
| Losartan Potassium | Losartan Potassium | 656 | 188 |
| Gabapentin | Gabapentin | 501 | 158 |
| Metformin Hcl | Metformin Hcl | 487 | 146 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 403 | 119 |
| Meloxicam | Meloxicam | 389 | 147 |
| Trazodone Hcl | Trazodone Hcl | 374 | 128 |
| Metoprolol Succinate | Metoprolol Succinate | 365 | 113 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 361 | 111 |
| Prednisone | Prednisone | 357 | 242 |
| Tamsulosin Hcl | Tamsulosin Hcl | 338 | 111 |
| Simvastatin | Simvastatin | 334 | 97 |
| Hydrochlorothiazide | Hydrochlorothiazide | 324 | 103 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 317 | 242 |
| Tramadol Hcl | Tramadol Hcl | 301 | 67 |
| Zolpidem Tartrate | Zolpidem Tartrate | 248 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 246 | 75 |
| Pantoprazole Sodium | Pantoprazole Sodium | 242 | 78 |
| Oxycodone Hcl | Oxycodone Hcl | 238 | 24 |
| Sertraline Hcl | Sertraline Hcl | 224 | 64 |
| Pravastatin Sodium | Pravastatin Sodium | 208 | 65 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 205 | 64 |
| Fluticasone Propionate | Fluticasone Propionate | 198 | 71 |
| Furosemide | Furosemide | 193 | 74 |
| Escitalopram Oxalate | Escitalopram Oxalate | 190 | 53 |
| Glipizide | Glipizide | 185 | 47 |
| Carvedilol | Carvedilol | 175 | 60 |
| Celecoxib | Celecoxib | 173 | 55 |
| Famotidine | Famotidine | 172 | 58 |
| Clopidogrel | Clopidogrel Bisulfate | 169 | 52 |
| Montelukast Sodium | Montelukast Sodium | 169 | 46 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 166 | 121 |
| Duloxetine Hcl | Duloxetine Hcl | 156 | 47 |
| Potassium Chloride | Potassium Chloride | 155 | 55 |
| Pregabalin | Pregabalin | 150 | 30 |
| Lorazepam | Lorazepam | 149 | 28 |
| Allopurinol | Allopurinol | 148 | 43 |
| Paroxetine Hcl | Paroxetine Hcl | 148 | 34 |
| Eliquis | Apixaban | 142 | 40 |
| Clonazepam | Clonazepam | 133 | 24 |
| Ezetimibe | Ezetimibe | 132 | 34 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 131 | 41 |
| Diazepam | Diazepam | 130 | 34 |
| Temazepam | Temazepam | 128 | 22 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 120 | 89 |
| Atenolol | Atenolol | 118 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 109 | 32 |
| Buspirone Hcl | Buspirone Hcl | 106 | 37 |
| Fluoxetine Hcl | Fluoxetine Hcl | 103 | 27 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 101 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 96 | 28 |
| Glipizide Er | Glipizide | 95 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 94 | 29 |
| Ropinirole Hcl | Ropinirole Hcl | 91 | 29 |
| Glimepiride | Glimepiride | 86 | 23 |
| Ibuprofen | Ibuprofen | 83 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 81 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 80 | 27 |
| Donepezil Hcl | Donepezil Hcl | 74 | 20 |
| Metformin Hcl Er | Metformin Hcl | 74 | 23 |
| Clonidine Hcl | Clonidine Hcl | 73 | 30 |
| Topiramate | Topiramate | 73 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 70 | 26 |
| Bupropion Hcl Sr | Bupropion Hcl | 69 | 20 |
| Finasteride | Finasteride | 68 | 21 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 67 | 13 |
| Fluconazole | Fluconazole | 66 | 43 |
| Aripiprazole | Aripiprazole | 65 | 20 |
| Clindamycin Hcl | Clindamycin Hcl | 65 | 48 |
| Quetiapine Fumarate | Quetiapine Fumarate | 64 | 16 |
| Meclizine Hcl | Meclizine Hcl | 63 | 28 |
| Baclofen | Baclofen | 61 | 19 |
| Fenofibrate | Fenofibrate | 61 | 14 |
| Spironolactone | Spironolactone | 60 | 24 |
| Valsartan | Valsartan | 58 | 18 |
| Warfarin Sodium | Warfarin Sodium | 58 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 57 | 12 |
| Estradiol | Estradiol | 56 | 20 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 55 | 40 |
| Doxazosin Mesylate | Doxazosin Mesylate | 53 | 16 |
| Ondansetron Odt | Ondansetron | 53 | 35 |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | 17 |
| Xarelto | Rivaroxaban | 49 | 14 |
| Benazepril Hcl | Benazepril Hcl | 48 | 12 |
| Bupropion Xl | Bupropion Hcl | 48 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 48 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 48 | 17 |
| Ozempic | Semaglutide | 48 | 12 |
| Synthroid | Levothyroxine Sodium | 48 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 47 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 47 | 13 |
| Bumetanide | Bumetanide | 46 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 46 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | 12 |
| Morphine Sulfate Er | Morphine Sulfate | 42 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 41 | 15 |
| Naproxen | Naproxen | 41 | 12 |
| Nitroglycerin | Nitroglycerin | 41 | 21 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 41 | 12 |
| Amoxicillin | Amoxicillin | 40 | 30 |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Sucralfate | Sucralfate | 40 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 39 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | suppressed |
| Mirtazapine | Mirtazapine | 38 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 20 |
| Acyclovir | Acyclovir | 37 | 17 |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Jardiance | Empagliflozin | 36 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 34 | 12 |
| Primidone | Primidone | 34 | 12 |
| Valacyclovir | Valacyclovir Hcl | 34 | 14 |
| Promethazine Hcl | Promethazine Hcl | 33 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | 11 |
| Irbesartan | Irbesartan | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 31 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 31 | suppressed |
| Clotrimazole | Clotrimazole | 30 | 20 |
| Alendronate Sodium | Alendronate Sodium | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 25 |
| Testosterone Cypionate | Testosterone Cypionate | 29 | 11 |
| Digoxin | Digoxin | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 25 |
| Divalproex Sodium | Divalproex Sodium | 26 | suppressed |
| Eszopiclone | Eszopiclone | 26 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Phenobarbital | Phenobarbital | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 23 |
| Lovastatin | Lovastatin | 25 | suppressed |
| Scopolamine | Scopolamine | 24 | suppressed |
| Testosterone | Testosterone | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 23 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 23 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Olanzapine | Olanzapine | 22 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Latanoprost | Latanoprost | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Metronidazole | Metronidazole | 21 | 20 |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 19 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Tadalafil | Tadalafil | 18 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Benzonatate | Benzonatate | 16 | 14 |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Sulfacetamide Sodium | Sulfacetamide Sodium | 16 | 11 |
| Dilt-Xr | Diltiazem Hcl | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Levemir | Insulin Detemir | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 14 |
| Modafinil | Modafinil | 14 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Methylphenidate Er | Methylphenidate Hcl | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 11 | suppressed |
| Naratriptan Hcl | Naratriptan Hcl | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Propylthiouracil | Propylthiouracil | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $162.40 · 9 records | AstraZeneca Pharmaceuticals LP | ACCRUFER, AIRSUPRA, AREXVY, BREZTRI, NUZYRA, TRELEGY ELLIPTA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error